Discovery and evaluation of potent, cysteine-based α4βl integrin antagonists

被引:4
作者
Archibald, SC [1 ]
Head, JC [1 ]
Linsley, JM [1 ]
Porter, JR [1 ]
Robinson, MK [1 ]
Shock, A [1 ]
Warrellow, GJ [1 ]
机构
[1] Celltech Chirosci, Slough SL1 4EN, Berks, England
关键词
D O I
10.1016/S0960-894X(00)00146-3
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Acyclic, disulphide derivatives of cysteine have been identified as moderately potent antagonists of alpha 4 beta 1-mediated leukocyte cell adhesion to VCAM. This communication describes how they were discovered from a simple L-cystine derivative and using the structure-activity data of C*DThioPC* related cyclic peptides. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:993 / 995
页数:3
相关论文
共 15 条
[1]   INTEGRIN-LIGAND BINDING - DO INTEGRINS USE A MIDAS TOUCH TO GRASP AN ASP [J].
BERGELSON, JM ;
HEMLER, ME .
CURRENT BIOLOGY, 1995, 5 (06) :615-617
[2]   ADHESION OF HUMAN BASOPHILS, EOSINOPHILS, AND NEUTROPHILS TO INTERLEUKIN 1-ACTIVATED HUMAN VASCULAR ENDOTHELIAL-CELLS - CONTRIBUTIONS OF ENDOTHELIAL-CELL ADHESION MOLECULES [J].
BOCHNER, BS ;
LUSCINSKAS, FW ;
GIMBRONE, MA ;
NEWMAN, W ;
STERBINSKY, SA ;
DERSEANTHONY, CP ;
KLUNK, D ;
SCHLEIMER, RP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (06) :1553-1556
[3]   VCAM-1 ON ACTIVATED ENDOTHELIUM INTERACTS WITH THE LEUKOCYTE INTEGRIN VLA-4 AT A SITE DISTINCT FROM THE VLA-4 FIBRONECTIN BINDING-SITE [J].
ELICES, MJ ;
OSBORN, L ;
TAKADA, Y ;
CROUSE, C ;
LUHOWSKYJ, S ;
HEMLER, ME ;
LOBB, RR .
CELL, 1990, 60 (04) :577-584
[4]  
ELICES MJ, 1998, CELL ADHESION MOL MA, P133
[5]  
HELMER ME, 1990, IMMUNOL REV, V114, P45
[7]   INTEGRINS - VERSATILITY, MODULATION, AND SIGNALING IN CELL-ADHESION [J].
HYNES, RO .
CELL, 1992, 69 (01) :11-25
[8]   CRYSTAL-STRUCTURE OF AN INTEGRIN-BINDING FRAGMENT OF VASCULAR CELL-ADHESION MOLECULE-1 AT 1.8 ANGSTROM RESOLUTION [J].
JONES, EY ;
HARLOS, K ;
BOTTOMLEY, MJ ;
ROBINSON, RC ;
DRISCOLL, PC ;
EDWARDS, RM ;
CLEMENTS, JM ;
DUDGEON, TJ ;
STUART, DI .
NATURE, 1995, 373 (6514) :539-544
[9]  
KOMORIYA A, 1991, J BIOL CHEM, V266, P15075
[10]  
Lobb R R, 1999, Expert Opin Investig Drugs, V8, P935, DOI 10.1517/13543784.8.7.935